Total Payments
$313.70
2024 Payments
$157.04
Companies
7
Transactions
15
Medicare Patients
1,140
Medicare Billing
$64,874
Payment Breakdown by Category
Food & Beverage$313.70 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $313.70 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $118.27 | 5 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $62.50 | 3 | $0 (2024) |
| Lilly USA, LLC | $45.87 | 3 | $0 (2024) |
| ABBVIE INC. | $30.23 | 1 | $0 (2024) |
| PFIZER INC. | $24.00 | 1 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $18.14 | 1 | $0 (2024) |
| Novo Nordisk Inc | $14.69 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.04 | 8 | GlaxoSmithKline, LLC. ($37.60) |
| 2023 | $156.66 | 7 | GlaxoSmithKline, LLC. ($80.67) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: VACCINES | ||||||
| 05/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Diabetes | ||||||
| 03/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VACCINES | ||||||
| 02/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: VACCINES | ||||||
| 10/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: VACCINES | ||||||
| 06/27/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 219 | 272 | $37,064 | $7,485 |
| 2022 | 6 | 221 | 295 | $55,308 | $9,187 |
| 2021 | 10 | 454 | 650 | $129,433 | $30,882 |
| 2020 | 7 | 246 | 389 | $81,195 | $17,321 |
Total Patients
1,140
Total Services
1,606
Medicare Billing
$64,874
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 64 | $24,787 | $3,679 | 14.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $4,143 | $1,369 | 33.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 63 | 87 | $1,653 | $724.08 | 43.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $3,437 | $564.65 | 16.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $1,518 | $496.98 | 32.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 51 | $1,020 | $485.52 | 47.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $506.00 | $165.66 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 103 | $38,312 | $5,510 | 14.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $4,371 | $1,504 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $6,457 | $887.11 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $3,251 | $513.93 | 15.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 49 | $980.00 | $470.13 | 48.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 72 | 103 | $1,938 | $301.33 | 15.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 150 | 286 | $84,753 | $17,784 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 56 | 56 | $16,576 | $6,104 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 59 | $11,930 | $2,699 | 22.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 16 | $6,354 | $1,791 | 28.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,533 | $805.75 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 95 | 137 | $2,603 | $411.00 | 15.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 11 | 11 | $1,067 | $388.63 | 36.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 29 | 37 | $740.00 | $359.27 | 48.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 23 | 23 | $1,058 | $352.59 | 33.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $819.00 | $186.05 | 22.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 174 | $51,166 | $10,561 | 20.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 86 | $17,281 | $3,628 | 21.0% |
About Devon Schneider, FNP
Devon Schneider, FNP is a Family healthcare provider based in Cottage Grove, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2011. The National Provider Identifier (NPI) number assigned to this provider is 1891070207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Devon Schneider, FNP has received a total of $313.70 in payments from pharmaceutical and medical device companies, with $157.04 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($313.70).
As a Medicare-enrolled provider, Schneider has provided services to 1,140 Medicare beneficiaries, totaling 1,606 services with total Medicare billing of $64,874. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cottage Grove, OR
- Active Since 10/17/2011
- Last Updated 10/28/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1891070207
Products in Payments
- SHINGRIX (Biological) $118.27
- REXULTI (Drug) $62.50
- MOUNJARO (Drug) $31.92
- QULIPTA (Drug) $30.23
- PAXLOVID (Drug) $24.00
- VOQUEZNA (Drug) $18.14
- Rybelsus (Drug) $14.69
- JARDIANCE (Drug) $13.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cottage Grove
Miss. Lisa Parker, Fnp-Bc, FNP-BC
Family — Payments: $295.12
Family $295.12
Mrs. Denise Rigo, Np, NP
Family — Payments: $261.76
Family $261.76
Rebecca Mcbride, Apn, APN
Family — Payments: $105.45
Family $105.45
Dr. Irene Wolf, Dnp, Aprn, Fnp-C, DNP, APRN, FNP-C
Family — Payments: $60.53
Family $60.53
Patience Nwokoro
Family — Payments: $38.65
Family $38.65
Sarah Siracusa, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $9.18
Family $9.18